A5 Labs submits EL application to Health Canada

Generally, all Canadian drug establishments must hold an EL to manufacture, package, or conduct testing of pharmaceutical products.

A5 Labs president and CEO Richard Azani said that in less than 4 months, their CRO team has completed all Standard Operating Procedures (SOPs) as well as validation protocols for all their instruments and Laboratory Information Management System (LIMS) to be able to conduct more than 1,000 testing methods.

"A5 Lab’s CRO has now completed all requirements to obtain the Health Canada Establishment License to start our Pharmaceutical analytical testing and development business," Azani said.